We have recently identified (Akhavan S et al., Thromb Haemost 2000; 84: 989-97) a patient with a mild bleeding diathesis associated to an homozygous mutation in the thrombin B chain (Gly25Ser, chymotrypsinogen numbering, i.e. position 330 in human prothrombin numbering). Transient transfection of wild-type prothrombin (FII-WT) and mutant prothrombin (designated FII-G25((330))S) cDNA in COS-7 cells showed a mild reduction (50%) in FII-G25((330))S production. Recombinant proteins, stably expressed in Chinese hamster ovary cells, were isolated and activated by TaYpan snake or Echis carinatus venoms. We show that the G25((330))S mutation results in a decrease in the rate of prothrombin proteolytic activation. The mutation also significantly decreases (i) the catalytic activity of thrombin with a 9-fold reduction in catalytic efficiency of the mutant toward S-2238; (ii) the interaction with benzamidine; (iii) the rate of inhibition by TLCK and antithrombin; and (iv) the rate of hydrolysis of macromolecular substrates (fibrinogen, protein C). In contrast, exosite I does not appear to be affected by the molecular defect. These results, together with molecular modeling and dynamics, indicate that Gly25((330)) is important for proper expression and probably proper folding of prothrombin, and also plays a critical role in both the alignment of the catalytic triad and the flexibility of one of the activation segments of prothrombin
A critical role for Gly25 in the B chain of human thrombin / S. Akhavan, M.A. Miteva, B.O. Villoutreix, L. Venisse, F. Peyvandi, P.M. Mannucci, M.C. Guillin, A. Bezeaud. - In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. - ISSN 1538-7933. - 3:1(2005 Jan), pp. 139-145.
A critical role for Gly25 in the B chain of human thrombin
F. Peyvandi;P.M. Mannucci;
2005
Abstract
We have recently identified (Akhavan S et al., Thromb Haemost 2000; 84: 989-97) a patient with a mild bleeding diathesis associated to an homozygous mutation in the thrombin B chain (Gly25Ser, chymotrypsinogen numbering, i.e. position 330 in human prothrombin numbering). Transient transfection of wild-type prothrombin (FII-WT) and mutant prothrombin (designated FII-G25((330))S) cDNA in COS-7 cells showed a mild reduction (50%) in FII-G25((330))S production. Recombinant proteins, stably expressed in Chinese hamster ovary cells, were isolated and activated by TaYpan snake or Echis carinatus venoms. We show that the G25((330))S mutation results in a decrease in the rate of prothrombin proteolytic activation. The mutation also significantly decreases (i) the catalytic activity of thrombin with a 9-fold reduction in catalytic efficiency of the mutant toward S-2238; (ii) the interaction with benzamidine; (iii) the rate of inhibition by TLCK and antithrombin; and (iv) the rate of hydrolysis of macromolecular substrates (fibrinogen, protein C). In contrast, exosite I does not appear to be affected by the molecular defect. These results, together with molecular modeling and dynamics, indicate that Gly25((330)) is important for proper expression and probably proper folding of prothrombin, and also plays a critical role in both the alignment of the catalytic triad and the flexibility of one of the activation segments of prothrombinFile | Dimensione | Formato | |
---|---|---|---|
j.1538-7836.2004.01086.x[1].pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
256.8 kB
Formato
Adobe PDF
|
256.8 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.